PREDICT: a checklist for preventing preanalytical diagnostic errors in clinical trials

Clin Chem Lab Med. 2020 Mar 26;58(4):518-526. doi: 10.1515/cclm-2019-1089.

Abstract

Although the importance of guaranteeing a high level of preanalytical quality in routine diagnostic testing has already been largely acknowledged over the past decades, minor emphasis is currently being placed on the fact that accurate performance and standardization of many preanalytical activities are also necessary prerogatives of clinical trials. Reliable evidence exists that clear indications on how to manage the different preanalytical steps are currently lacking in many clinical trials protocols, nor have detailed authoritative documents been published or endorsed on this matter to the best of our knowledge. To fill this gap, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE) will provide here a specific checklist for preventing preanalytical diagnostic errors in clinical trials (PREDICT), especially focused on covering the most important preanalytical aspects of blood sample management in clinical studies, and thus encompassing test selection, patient preparation, sample collection, management and storage, sample transportation, as well as specimen retrieval before testing. The WG-PRE members sincerely hope that these recommendations will provide a useful contribution for increasing the success rate in clinical trials.

Keywords: clinical trials; errors; laboratory medicine; preanalytical variability; studies.

MeSH terms

  • Blood Specimen Collection / methods
  • Blood Specimen Collection / standards
  • Checklist
  • Clinical Laboratory Techniques / standards*
  • Clinical Trials as Topic
  • Diagnostic Errors / prevention & control*
  • Humans
  • Pre-Analytical Phase